DIN 02370921 — TRAJENTA 5 MG
TRAJENTA is a tablet of Linagliptin marketed by BOEHRINGER INGELHEIM (CANADA) LTD LTEE. The full Linagliptin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02370921
- Brand name
- TRAJENTA
- Active ingredient
- Linagliptin
- Strength
- 5 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- BOEHRINGER INGELHEIM (CANADA) LTD LTEE
- Health Canada status
- MARKETED
- Drug class
- Dipeptidyl peptidase-4 (DPP-4) inhibitor
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.